Jefferies cuts Booz Allen Hamilton stock price target on revenue concerns

Jefferies cut Booz Allen Hamilton’s price target to $85 from $110 while keeping a Hold rating, citing expected fiscal 2026 revenue decline of 5% and guidance of -5% to -6% versus prior 0% to 4% growth. The stock is down about 41% since the start of 2025 and trades at $74.92, just above its 52-week low of $73.93, while Jefferies sees only a modest fiscal 2027 recovery with flat revenue and EPS of $6.00 to $6.35. The article also notes ongoing dividend payments for 15 straight years and recent defense-tech investments, but the analyst downgrade and weaker growth outlook dominate.

Analysis

BAH looks less like a cyclical slowdown and more like a credibility reset: the market is no longer paying for its historical growth algorithm because guidance has broken the pattern. That matters because government-services multiples typically compress faster than earnings estimates when investors start discounting a structurally lower end-market growth rate, so the stock can stay cheap even if the next print is merely “less bad.” The dividend yield provides downside support, but it is not enough to offset a prolonged de-rating if revenue remains negative into FY27.

The second-order effect is pressure on the broader defense IT/services complex, especially firms exposed to federal digital transformation, consulting, and program execution. If BAH is struggling to sustain growth despite its scale and brand, the market may conclude that procurement timing and contract recompete friction are worsening across the niche, which could spill into peers with similar mix but less balance-sheet flexibility. That said, the investments in drones and autonomy signal management is trying to reposition the franchise toward faster-growing pockets of defense tech, and those initiatives could matter more in the stock once investors believe the core book has stabilized.

The key catalyst window is the May 22 earnings print and, more importantly, the FY27 guide/qualitative commentary. A clean setup would be a revenue trough plus evidence that margins can expand even on flat sales; without that, the stock remains a value trap with a 3% yield. The contrarian read is that expectations are already so damaged that a modestly better-than-feared guide could produce a sharp squeeze, but the burden of proof is now on management, not the sell side.

Key Decisions for Investors

• Maintain or add to a short BAH position into the May 22 print if the stock rallies toward the mid-$80s; risk/reward remains favorable as the market is likely to keep assigning a lower terminal growth multiple until management proves FY27 stabilization.
• Use a bearish options structure on BAH for the earnings window: buy 1-2 month puts or put spreads targeting a post-earnings move lower if guidance confirms another year of revenue contraction; cap premium because the stock is already near support.
• Pair trade: long HII / short BAH over 3-6 months if you want defense exposure; HII has a cleaner path to budget-led backlog conversion while BAH is more exposed to consulting/margin skepticism.
• If long-term value investors want exposure, wait for confirmation of a FY27 revenue trough before initiating; current entry offers yield support but poor visibility, so the odds favor a lower re-entry point unless management surprises materially.
• Monitor the first comment on autonomous systems/AI-driven contract wins; if those investments start showing booked revenue rather than venture-style optionality, reassess for a tactical long as the market may re-rate the story from ‘stalled services’ to ‘defense tech optionality.’